Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim for Chemotherapy-Induced Thrombocytopenia in Lymphoma
NCT00283439Phase 2Completed
- Sponsor
- Amgen
- Start
- Oct 2005
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of romiplostim in Thrombocytopenia, sponsored by Amgen. Started Oct 2005; status: completed.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00283439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00283439.